Intra Cellular Therapies reported -0.78 in EPS Earnings Per Share for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Acadia Pharmaceuticals ACAD:US $ -0.7K 0.7K
ALKERMES ALKS:US $ 0.12 0.11
Aptinyx Inc APTX:US -0.29 0
Biocryst Pharmaceuticals BCRX:US -0.4 0
Biogen BIIB:US $ 3.62 0.23
Bristol Myers Squibb BMY:US $ 1.96 0.13
Cytokinetics CYTK:US -1.02 0.66
Esperion Therapeutics ESPR:US -0.93 0.84
Gilead Sciences GILD:US $ 2.12 1.43
Halozyme Therapeutics HALO:US $ 0.47 0.01
Intra Cellular Therapies ITCI:US -0.78 0.27
JAZZ PHA JAZZ:US $ 3.73 0.48
Johnson & Johnson JNJ:US 2.67 0.54
Marinus Pharmaceuticals MRNS:US $ -0.52 0.25
Minerva Neurosciences NERV:US $ -0.23 0.27
Nektar Therapeutics NKTR:US $ -0.79 0.09
Neurocrine Biosciences NBIX:US $ 0.3 0.38
Novartis NVS:US $ 1.46 0.06
Prothena PRTA:US -0.78 0.07
Redhill Biopharma RDHL:US $ -0.5 0
Supernus Pharmaceuticals SUPN:US 0.29 0.11
United Therapeutics UTHR:US $ 3.59 1.24
Vanda Pharmaceuticals VNDA:US $ -0.11 0.23